CG Oncology Raises $120 Million in Oversubscribed Series E Financing to Advance Clinical-Stage Urologic Oncology Pipeline

– Co-led by ORI Capital, Longitude Capital and Decheng Capital, with participation from RA Capital Management, Acorn Bioventures, Malin Corporation, Ally Bridge Group and Sirona Capital – – Proceeds to accelerate clinical programs across bladder cancer including in the first-line setting, positioning CG Oncology as the leading urologic oncology company – – Brian Liu, M.D., … [Read more…]

Casma Therapeutics Raises $46.0 M in Series C Funding

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Casma Therapeutics, Inc., a biotechnology company engaging the autophagy system to provide innovative new medicines, today announced the closing of a Series C financing round of $46.0 million. New investors participating in the round include Amgen Ventures, LLC, Astellas Venture Management, Eisai Co., Ltd., Euclidean Capital, Mirae Asset, and Ono Venture Investment. Current … [Read more…]

Castle Biosciences Presents New Data Demonstrating the Clinical Utility and Value of DecisionDx®-SCC in Moderately and Poorly Differentiated Cutaneous Squamous Cell Carcinoma Tumors

Study finds that DecisionDx-SCC adds clarity and confidence to risk-aligned treatment decisions, independent of clinicopathologic factors and staging FRIENDSWOOD, Texas–(BUSINESS WIRE)–$CSTL #CSTL–Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data showing how the Company’s DecisionDx®-SCC test can provide objective, independent and significant risk-stratification for … [Read more…]

University of Denver Study Shows King-Devick Test in association with Mayo Clinic is an Accurate Tool for Detecting, Tracking and Measuring the Severity of Long COVID

Proven concussion test would be the first product to aid in detecting Long COVID CHICAGO–(BUSINESS WIRE)–A recent study conducted by researchers at the University of Denver and published in noted medical journal medRXiv, found that King-Devick Test in association with Mayo Clinic (King-Devick Test) was highly sensitive to Long COVID and may be a reliable … [Read more…]

AlloVir to Participate in the Piper Sandler 34th Annual Healthcare Conference

WALTHAM, Mass.–(BUSINESS WIRE)–AlloVir, Inc. (Nasdaq: ALVR), a late-clinical stage allogeneic T-cell immunotherapy company, today announced that Diana Brainard, M.D., Chief Executive Officer, will participate in a fireside chat at the Piper Sandler 34th Annual Healthcare Conference in New York on Tuesday, November 29, 2022, at 12:00 p.m. ET. A live webcast and archived replay of … [Read more…]

BeiGene Launches Talk About It Program to Elevate the Importance of Addressing Mental Health during Cancer Care

CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–$BGNE #BeiGene–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the launch of a new program, Talk About It: Cancer and Mental Health, designed to elevate the important intersection of mental health and cancer care to help improve health outcomes for cancer patients. Aimed … [Read more…]

Avanzanite Bioscience Launches Novel Business Model to Commercialize Innovative Medicines for Rare Diseases in Europe

Establishes first-in-class biopharmaceutical commercialization platform specifically addressing rare diseases in Europe Secured exclusive rights in 26 European Countries to an investigational orphan medicine for the treatment of an ultra-rare ophthalmologic disease, currently under review by the European Medicines Agency for marketing approval Founded by biopharmaceutical executives Adam Plich, CEO, and Anant Murthy, Board Advisor, with … [Read more…]

Fideres Study Believes UK Water Companies Potentially in Breach of Competition Law Over Raw Sewage Spills

Economic consultancy believes that water companies’ behaviour may amount to an abuse of competition laws that could entitle UK households to compensation LONDON–(BUSINESS WIRE)–#UK–Today Fideres released new research into the potential harm suffered by UK consumers as a result of raw sewage spills over the past six years. Fideres found that the water companies’ conduct … [Read more…]

Ablexis and AlivaMab Discovery Services Announce Expansion of Antibody Drug Discovery and Engineering Capabilities

New platforms and capabilities further enable partners to advance better antibody drugs faster. SAN DIEGO–(BUSINESS WIRE)–Ablexis, LLC (“Ablexis”), a biopharmaceutical company focused on licensing its AlivaMab® Mouse technology for antibody drug discovery, and AlivaMab Discovery Services, LLC (“ADS”), a leader in the discovery of superior antibody-based therapeutics, which together are leading providers of solutions for … [Read more…]

Global Digestive Enzyme Supplements Market Report 2022 to 2028: Featuring ProThera, Enzymes, AST Enzymes and Vemo 99 Among Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Digestive Enzyme Supplements Market Size, Share & Industry Trends Analysis Report By Application (Additional supplements, Medical & Infant Nutrition and Sports Nutrition), By Origin (Animal, Plant, Microbial), By Regional Outlook and Forecast, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Global Digestive Enzyme Supplements Market size is expected to … [Read more…]